Results for "Xenotransplantation"

20 articles

How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists
Regenerative Medicine

How Pig Organs, Bioprinted Tissue and Stem Cells Could End Transplant Waitlists

Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.

Press Release
May 28, 2026 0
CAR T-Cell Therapy Clears Immune Barriers to Enable Kidney Transplants in Near-Impossible Cases
Longevity & Aging

CAR T-Cell Therapy Clears Immune Barriers to Enable Kidney Transplants in Near-Impossible Cases

A novel dual CAR T-cell approach eliminated blocking antibodies in highly sensitized patients, enabling kidney transplants previously considered impossible.

Press Release
Jun 4, 2026 0
LyGenesis Targets Type 1 Diabetes with Lymph Node Organ Regeneration Tech
Longevity & Aging

LyGenesis Targets Type 1 Diabetes with Lymph Node Organ Regeneration Tech

LyGenesis wins funding to develop immune tolerance for pancreatic islet transplants, using its novel lymph node organ-growing platform.

Press Release
Jun 30, 2026 0
FDA Approves LungFX Device to Rescue Donor Lungs Rejected for Transplant
Longevity & Aging

FDA Approves LungFX Device to Rescue Donor Lungs Rejected for Transplant

United Therapeutics wins FDA approval for LungFX, a device that keeps donor lungs viable outside the body for transplant reassessment.

Press Release
Jul 1, 2026 0
Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them
Longevity & Aging

Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them

A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace — not just repair — aging biology.

Press Release
May 1, 2026 0
Gene-Edited Islet Cells Treat Type 1 Diabetes Without Anti-Rejection Drugs
Longevity & Aging

Gene-Edited Islet Cells Treat Type 1 Diabetes Without Anti-Rejection Drugs

Sana Biotechnology's hypoimmune cell therapy may eliminate the need for lifelong immunosuppression in type 1 diabetes transplants.

Press Release
Jul 3, 2026 0
FDA Approves First Treg Cell Therapy Cutting Blood Cancer Transplant Complications in Half
Longevity & Aging

FDA Approves First Treg Cell Therapy Cutting Blood Cancer Transplant Complications in Half

Tregzi slashes chronic graft-versus-host disease rates from 44% to 12.6%, offering new hope for stem cell transplant patients.

Press Release
Jul 1, 2026 0
UC Berkeley Startup Uses Jumping Genes to Deliver Lasting GLP-1 Weight Loss Therapy
Regenerative Medicine

UC Berkeley Startup Uses Jumping Genes to Deliver Lasting GLP-1 Weight Loss Therapy

A UC Berkeley spinout is developing a one-time gene therapy using transposons to sustain GLP-1 activity — potentially replacing daily weight loss drugs.

Press Release
Apr 25, 2026 0
New Liver Perfusion Technique Cuts Transplant Complications by Nearly Half
Longevity & Aging

New Liver Perfusion Technique Cuts Transplant Complications by Nearly Half

A randomized trial found hypothermic oxygenated perfusion slashed early graft failure rates from 37% to 20% in liver transplant patients.

Press Release
May 28, 2026 0
Gene Therapy Breakthrough Delivers Treatment Directly to the Brain
Longevity & Aging

Gene Therapy Breakthrough Delivers Treatment Directly to the Brain

JCR Pharmaceuticals shows its JUST-AAV platform can cross the blood-brain barrier, extending survival in neurological disease mouse models.

Press Release
May 20, 2026 0
Diabetes Dramatically Raises Death Risk in Organ Transplant Recipients
Longevity & Aging

Diabetes Dramatically Raises Death Risk in Organ Transplant Recipients

A 732,000-patient study finds both pre-existing and new-onset diabetes sharply increase 10-year mortality across four major transplanted organs.

Press Release
Jun 15, 2026 0
Lab-Grown Blood Cells Match Donor Survival Time in Landmark Biotech Result
Longevity & Aging

Lab-Grown Blood Cells Match Donor Survival Time in Landmark Biotech Result

Scarlet Therapeutics grows universal red blood cells that survive as long as donated ones, opening a path to engineered therapeutic blood.

Press Release
May 12, 2026 0
Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics
Longevity & Aging

Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics

Sana Biotechnology and Mayo Clinic are advancing SC451, a cell therapy that may restore natural insulin production without immunosuppression.

Press Release
May 1, 2026 0
Finnish Biotech Awards $30K to Cleveland Clinic for Organ Transplant Research
Longevity & Aging

Finnish Biotech Awards $30K to Cleveland Clinic for Organ Transplant Research

NADMED funds groundbreaking research on metabolic assessment of donor organs, advancing redox biology toward real-world longevity medicine.

Press Release
Apr 10, 2026 0
Scientists Create Cancer-Fighting CAR T Cells Directly Inside Living Mice
Cancer Research

Scientists Create Cancer-Fighting CAR T Cells Directly Inside Living Mice

Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.

Press Release
Mar 28, 2026 0
New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection
Cancer Research

New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection

Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.

Press Release
Mar 28, 2026 3
Single-Dose Gene Therapy Cuts LDL Cholesterol by 68% in Primate Study
Longevity & Aging

Single-Dose Gene Therapy Cuts LDL Cholesterol by 68% in Primate Study

Scribe Therapeutics reports a one-time epigenetic therapy slashed LDL cholesterol up to 68% for nearly two years in primates.

Press Release
May 30, 2026 0
FDA Approves Orca Bio T Cell Therapy That Cuts Graft-Versus-Host Disease Risk
Longevity & Aging

FDA Approves Orca Bio T Cell Therapy That Cuts Graft-Versus-Host Disease Risk

Tregzi, a personalized T cell therapy, wins FDA approval to reduce dangerous immune complications in blood cancer stem cell transplant patients.

Press Release
Jul 2, 2026 0
World's First Human Kidney Regeneration Surgery Set to Launch in July 2026
Longevity & Aging

World's First Human Kidney Regeneration Surgery Set to Launch in July 2026

Rokit Healthcare gains clinical approval to begin human trials using bioprinted omentum patches to regenerate damaged kidneys.

Press Release
Jun 13, 2026 0
In Vivo CAR-T Cell Therapy Aims to Simplify Cancer Immunotherapy
Regenerative Medicine

In Vivo CAR-T Cell Therapy Aims to Simplify Cancer Immunotherapy

Next-gen CAR-T approaches skip the lab and engineer immune cells directly inside the body, potentially making cancer therapy faster and cheaper.

Press Release
Apr 30, 2026 0
Page 1 of 2Next